High-Dose Intravenous Vitamin C (IVC)

High-Dose Intravenous Vitamin C (IVC) is tracked in this database as a cancer-related diet or nutrition protocol. It appears in cancer-related discussions because patients, clinicians, authors, clinics, researchers, or alternative-health communities have connected it with cancer prevention, active treatment, treatment support, symptom relief, recovery, or survivorship. The purpose of this entry is to describe what the protocol is, how it is usually framed, and what kind of caution belongs around it.

This entry is not a recommendation to use the protocol. It is a structured research note so that books, articles, videos, organizations, individuals, and related diseases can be connected in one place.

How It Connects With Cancer

High-Dose Intravenous Vitamin C (IVC) is discussed for nutrition status, metabolic support, inflammation, digestion, immune resilience, treatment tolerance, or alternative cancer-treatment claims. Some sources discuss it as a direct anticancer strategy, while others frame it as supportive care, quality-of-life care, nutrition support, symptom management, rehabilitation, or a way to improve resilience during conventional treatment.

The practical question is not simply whether the topic is "good" or "bad." The important questions are what cancer setting it is being discussed for, whether it is meant to replace or accompany conventional oncology, what evidence supports the claim, what risks or interactions exist, and whether the patient can be monitored appropriately.

Evidence and Controversy

Some parts may overlap with reasonable oncology nutrition, while stronger claims about tumor control or cure are often unproven, mixed, or controversial. Strong claims about curing cancer, shrinking tumors, detoxifying the body, repairing DNA, activating immunity, or replacing standard treatment should be separated from more modest claims such as improving comfort, nutrition, sleep, mood, function, or treatment tolerance.

For research review, this protocol should be connected to both supportive and critical sources when available. Positive reports, practitioner experience, case histories, mechanistic papers, clinical trials, safety warnings, regulatory actions, and skeptical reviews can all be useful, as long as they are clearly labeled and not treated as equal levels of evidence.

Safety and Practical Considerations

Major diet changes can affect weight, blood sugar, kidney function, bowel function, medication tolerance, and recovery from chemotherapy, surgery, radiation, or immunotherapy. Cancer patients may have special vulnerabilities, including immune suppression, bleeding risk, bowel obstruction, cachexia, organ impairment, implanted devices, neuropathy, surgical wounds, drug interactions, or rapidly changing disease status.

Before using this protocol in a real care plan, patients should review it with clinicians who understand their diagnosis, stage, pathology, current treatment, medications, lab results, and goals of care. This is especially important when a protocol involves ingesting substances, injections, devices, fasting, detoxification, heat, electrical current, intense breathwork, or abandoning established treatment.

WooWoo Scale Placement

This protocol is currently placed at 6 / 10 on the database scale: Alternative. The score is intended as an organizational signal, not a moral judgment. It helps separate conventional oncology, recognized integrative care, diet and supplement approaches, functional or independent methods, alternative systems, experimental approaches, unapproved therapies, technical healing methods, and spiritual or distance-healing claims.

Contraindications and Precautions

Supporters of high-dose intravenous (IV) vitamin C generally do not identify specific cancer types that absolutely should not receive the therapy. Instead, they emphasize several important contraindications and precautions. The most commonly cited concern involves patients with multiple myeloma who are being treated with the proteasome inhibitor Bortezomib, as laboratory studies have suggested vitamin C may reduce the drug's effectiveness. Many practitioners also recommend careful coordination when IV vitamin C is used alongside certain chemotherapy regimens for leukemias and lymphomas. Before treatment, reputable clinics typically screen for Glucose-6-phosphate dehydrogenase deficiency, since high-dose vitamin C can cause dangerous destruction of red blood cells in affected individuals. Additional precautions include significant kidney disease, a history of recurrent calcium oxalate kidney stones, impaired kidney function, iron overload disorders such as Hemochromatosis, and careful monitoring in patients with fluid overload or heart failure, where large IV infusions may not be well tolerated. Many integrative practitioners also recommend scheduling IV vitamin C carefully around chemotherapy or radiation treatments to minimize the possibility of interactions.